Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074666 · ClinicalTrials.gov registry record · NA
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
A NA study of Acute Lymphoblastic Leukemia, Pediatric, sponsored by Roswell Park Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06074666: Recruiting NA study of Acute Lymphoblastic Leukemia, Pediatric, sponsored by Roswell Park Cancer Institute.
NCT06074666 is a NA study of Acute Lymphoblastic Leukemia, Pediatric that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 100 participants, below the 111-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06074666, a NA study of Acute Lymphoblastic Leukemia, Pediatric, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
Primary Outcome
enrollment rates will be measured by number of consents . Reasons for refusal will also be captured
Conditions Studied
Interventions
- BEHAVIORAL CareMeds Intervention
- BEHAVIORAL Usual Care Group
Study Locations (1)
New York
- Roswell Park Comprehensive Cancer Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-11-07 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT06074666 shows while recruiting
NCT06074666 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 111-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Acute Lymphoblastic Leukemia, Pediatric appearing as the primary indexed condition, and to 2 interventions - of which CareMeds Intervention is the first listed.
NCT06074666 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06074666 about?
NCT06074666 is a clinical study titled "Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3". The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
What is the current status of trial NCT06074666?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-11-07. Estimated completion is 2027-10-01.
What conditions does trial NCT06074666 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia, Pediatric.
What interventions are being tested in trial NCT06074666?
The interventions under investigation include: CareMeds Intervention (BEHAVIORAL), Usual Care Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT06074666?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06074666 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia, Pediatric
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06074666's enrollment target sits among peer trials
100 2nd of 8 the highest of 8 other Acute Lymphoblastic Leukemia, Pediatric trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Lymphoblastic Leukemia, Pediatric trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
RECRUITING · NA
-
Low GI Diet in Children and Adolescents With ALL
ACTIVE NOT RECRUITING · NA
-
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
RECRUITING · Phase 1
-
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI